@article{article, title = {{A Phase Ib/II study of IGF-neutralising antibody xentuzumab with enzalutamide in metastatic castration-resistant prostate cancer}}, publisher = {{Springer Science and Business Media LLC}}, url = {{http://dx.doi.org/10.1038/s41416-023-02380-1 }}, year = {{2023}}, month = {{8}}, author = {{Macaulay VM and Lord S and Hussain S and Maroto JP and Jones RH and Climent MÁ and Cook N and Lin C-C and Wang S-S and Bianchini D and Bailey M et al}}, doi = {{10.1038/s41416-023-02380-1}}, journal = {{British Journal of Cancer}}, note = {{Accessed on 2024/12/22}}}